Overview consensus statement. Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer.
Garnick
M B
MB
Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. Marc.Garnick@praecis.com
Fair
W R
WR
Bostwick
D
D
Debruyne
F
F
Fourcroy
J
J
Grignon
D
D
Porterfield
H
H
Sufrin
G
G
Thrasher
B
B
Hart
C
C
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy; D011467:Prostate / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D011788:Quality of Life; D012107:Research Design
D018931:Antineoplastic Agents, Hormonal; D017430:Prostate-Specific Antigen